2022 Vaccine Market Report

Vaccine Market ReportThe U.S. vaccine market is expected to reach $30 billion by 2027, fueled by COVID-19 vaccines, development of new vaccine technologies, and advances in clinical research. The growth and approval of pediatric vaccinations and universal vaccine trials have also significantly contributed to the market expansion. The 2022 Vaccine Market Report describes the overall vaccine market, including the approval process, the impact of the COVID-19 pandemic, necessary vaccine supplies and market value for childhood, adult, influenza, and COVID-19 vaccines.

Key Findings
  • 11.3 billion doses of COVID-19 vaccines were administered globally.
  • An estimated 11.1 million adult and adolescent vaccines were missed in 2021.
  • Pharmacies administered 14.9% less flu vaccines in 2022 compared to 2021.
  • In 2021, Pfizer sold $36 billion in vaccines breaking the 2015 record of $6.2 billion.
 
Picture of the product2022 Market Report: Vaccine (PDF)
**PDF License: Easily shareable with your whole team, an organization-wide PDF license is available for immediate download.**
The 2022 Vaccine Market Report analyzes major market trends impacting the vaccine industry and discusses key vaccines already in the market including COVID-19, flu, adult, children, adolescent and travel vaccines.

  • HIDA member: $1,550
  • Non-member: $2,500


Regular price: 2,500.00
Discounted member price: 1,550.00
Quantity   

 
MR2201PDF
Picture of the product2022 Market Report: Vaccine (Print)
**Printed Report**
The 2022 Vaccine Market Report analyzes major market trends impacting the vaccine industry and discusses key vaccines already in the market including COVID-19, flu, adult, children, adolescent and travel vaccines.

  • HIDA member: Complimentary - 1 copy only ($499 value); call for bulk pricing
  • Non-member: $799


Regular price: 799.00
Discounted member price: 499.00
Quantity   

 
MR2201

My Cart

Items

There are no records.

 
 
You May Also Like: